Diagnostic potential of plasma CD30(+) small extracellular vesicles in Hodgkin lymphoma
Background. In current clinical practice, there are no reliable methods to stratify patients with a high risk of relapse or with a primary refractory form of Hodgkin lymphoma. Quantification of CD30-positive small extracellular vesicles (CD30(+)SEV) in plasma seems to be a possible approach to solve...
Saved in:
| Main Authors: | K. E. Katsuba, L. A. Kramynin, M. A. Slyusarenko, A. V. Shalaev, V. V. Sharoyko, A. A. Valitova, A. S. Artem’eva, P. I. Krzhivitskiy, L. V. Filatova, A. V. Malek |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-12-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/875 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual-pathological cascade delivery of apoptotic vesicles for targeted therapy in intervertebral disc degeneration
by: Wei Chen, et al.
Published: (2025-10-01) -
EXPERIENCE IN THE TREATMENT OF REFRACTORY HODGKIN’S LYMPHOMA
by: A. M. Chervontseva, et al.
Published: (2021-03-01) -
Value of accelerated hyperfraction dozes of radiation in primary radiation treatment for Hodgkin’s lymphoma
by: N. V. Ilyin, et al.
Published: (2022-11-01) -
Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience
by: K. V. Lepik, et al.
Published: (2019-01-01) -
COMPLEX ESTIMATION OF BRONCHOPULMONARY SYSTEM IN PATIENTS WITH HODGKINS LYMPHOMA
by: Yu. N. Obgolts, et al.
Published: (2012-02-01)